Interaction of the glucocorticoid receptor and the chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII): Implications for the actions of glucocorticoids on glucose, lipoprotein, and xenobiotic metabolism

Annals of the New York Academy of Sciences

Volumn 1024, Issue , 2004, Pages 72-85

  De Martino, Massimo U ^a   Alesci, Salvatore ^a   Chrousos, George P ^a   Kino, Tomoshige ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Apolipoproteins; Cholesterol; Gluconeogenesis; P450 CYP3A; P450 CYP7A; Phosphoenolpyruvate carboxykinase (PEPCK); Protein protein interaction; Xenobiotic metabolism

Indexed keywords

CELL NUCLEUS RECEPTOR; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR; CYTOCHROME P450; CYTOCHROME P450 3A; CYTOCHROME P450 7A; GLUCOCORTICOID RECEPTOR; GLUCOSE; HORMONE RECEPTOR; LIPOPROTEIN; NUCLEAR RECEPTOR COREPRESSOR; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); RECEPTOR SUBTYPE; SILENCING MEDIATOR FOR RETINOID AND THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

CARBOXY TERMINAL SEQUENCE; CENTRAL NERVOUS SYSTEM; CHOLESTEROL METABOLISM; CONFERENCE PAPER; ENZYME REGULATION; GENE TARGETING; GLUCONEOGENESIS; GLUCOSE METABOLISM; HUMAN; LIPOPROTEIN METABOLISM; MOLECULAR INTERACTION; NONHUMAN; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR INTRINSIC ACTIVITY; TRANSACTIVATION; TRANSCRIPTION INITIATION; XENOBIOTIC METABOLISM;

GALLUS GALLUS; STAPHYLOCOCCUS PHAGE 3A;

EID: 3042759123     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1321.006     Document Type: Conference Paper

References (83)

1. ORTH, D.N. & W.J. KOVACS. 1998. The adrenal cortex. In Williams Textbook of Endocrinology. J.D. Wilson, D.W. Foster, H.M. Kronenberg & P.R. Larsen, Eds.: 517-664. W.B. Saunders Co. Philadelphia.
2. MUNCK, A., P.M. GUYRE & N.J. HOLBROOK. 1984. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr. Rev. 5: 25-44.
3. CLARK, J.K., W.T. SCHRADER & B.W. O'MALLEY. 1992. Mechanism of steroid hormones. In Williams Textbook of Endocrinology. J.D. Wilson & D.W. Foster, Eds.: 35-90. W.B. Saunders Co. Philadelphia.
4. BOUMPAS, D.T., G.P. CHROUSOS, R.L. WILDER, et al. 1993. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann. Intern. Med. 119: 1198-1208.
5. KINO, T. & G.P. CHROUSOS. 2001. Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes. J. Endocrinol. 169: 437-445.
6. BEATO, M. & A. SANCHEZ-PACHECO. 1996. Interaction of steroid hormone receptors with the transcription initiation complex. Endocr. Rev. 17: 587-609.
7. BAMBERGER, C.M., H.M. SCHULTE & G.P. CHROUSOS. 1996. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr. Rev. 17: 245-261.
8. CALDENHOVEN, E., J. LIDEN, S. WISSINK, et al. 1995. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol. Endocrinol. 9: 401-412.
9. MCKAY, L.I. & J.A. CIDLOWSKI. 2000. CBP (CREB binding protein) integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism. Mol. Endocrinol. 14: 1222-1234.
10. NISSEN, R.M. & K.R. YAMAMOTO. 2000. The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxyterminal domain. Genes Dev. 14: 2314-2329.
11. REICHARDT, H.M., K.H. KAESTNER, J. TUCKERMANN, et al. 1998. DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93: 531-541.
12. COLE, T.J., J.A. BLENDY, A.P. MONAGHAN, et al. 1995. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev. 9: 1608-1621.
13. REICHARDT, H.M., J.P. TUCKERMANN, M. GOTTLICHER, et al. 2001. Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J. 20: 7168-7173.
14. STOCKLIN, E., M. WISSLER, F. GOUILLEUX & B. GRONER. 1996. Functional interactions between Stat5 and the glucocorticoid receptor. Nature 383: 726-728.
15. SCHULE, R., P. RANGARAJAN, S. KLIEWER, et al. 1990. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62: 1217-1226.
16. IMAI, E., J.N. MINER, J.A. MITCHELL, et al. 1993. Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids. J. Biol. Chem. 268: 5353-5356.
17. CHANG, T.J., B.M. SCHER, S. WAXMAN & W. SCHER. 1993. Inhibition of mouse GATA-1 function by the glucocorticoid receptor: possible mechanism of steroid inhibition of erythroleukemia cell differentiation. Mol. Endocrinol. 7: 528-542.
18. PIERREUX, C.E., J. STAFFORD, D. DEMONTE, et al. 1999. Antiglucocorticoid activity of hepatocyte nuclear factor-6. Proc. Natl. Acad. Sci. USA 96: 8961-8966.
19. PREFONTAINE, G.G., M.E. LEMIEUX, W. GIFFIN, et al. 1998. Recruitment of octamer transcription factors to DNA by glucocorticoid receptor. Mol. Cell. Biol. 18: 3416-3430.
20. SENGUPTA, S., J.L. VONESCH, C. WALTZINGER, et al. 2000. Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells. EMBO J. 19: 6051-6064.
21. KUSK, P., S. JOHN, G. FRAGOSO, et al. 1996. Characterization of an NF-1/CTF family member as a functional activator of the mouse mammary tumor virus long terminal repeat 5′ enhancer. J. Biol. Chem. 271: 31269-31276.
22. PHILIPS, A., M. MAIRA, A. MULLICK, et al. 1997. Antagonism between Nur77 and glucocorticoid receptor for control of transcription. Mol. Cell. Biol. 17: 5952-5959.
23. BORUK, M., J.G. SAVORY & R.J. HACHE. 1998. AF-2-dependent potentiation of CCAAT enhancer binding protein beta-mediated transcriptional activation by glucocorticoid receptor. Mol. Endocrinol. 12: 1749-1763.
24. DE MARTINO, M.U., N. BHATTACHRYYA, S. ALESCI, et al. 2004. The glucocorticoid receptor (GR) and the orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) interact with and mutually affect each other's transcriptional activities: implications for intermediary metabolism. Mol. Endocrinol. In press.
25. QIU, Y., V. KRISHNAN, F.A. PEREIRA, et al. 1996. Chicken ovalbumin upstream promoter-transcription factors and their regulation. J. Steroid Biochem. Mol. Biol. 56: 81-85.
26. MANGELSDORF, D.J., C. THUMMEL, M. BEATO, et al. 1995. The nuclear receptor superfamily: the second decade. Cell 83: 835-839.
27. KINO, T., A. VOTTERO, E. CHARMANDARI & G.P. CHROUSOS. 2002. Familial/sporadic glucocorticoid resistance syndrome and hypertension. Ann. N.Y Acad. Sci. 970: 101-111.
28. HOLLENBERG, S.M., C. WEINBERGER, E.S. ONG, et al. 1985. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318: 635-641.
29. VOTTERO, A. & G.P. CHROUSOS. 1999. Glucocorticoid receptor beta: view I. Trends Endocrinol. Metab. 10: 333-338.
30. ALMLOF, T., A.E. WALLBERG, J.A. GUSTAFSSON & A.P. WRIGHT. 1998. Role of important hydrophobia amino acids in the interaction between the glucocorticoid receptor tau 1-core activation domain and target factors. Biochemistry 37: 9586-9594.
31. WARNMARK, A., J.A. GUSTAFSSON & A.P. WRIGHT. 2000. Architectural principles for the structure and function of the glucocorticoid receptor tau 1 core activation domain. J. Biol. Chem. 275: 15014-15018.
32. LUISI, B.F., W.X. XU, Z. OTWINOWSKI, et al. 1991. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. 1H NMR studies of the glucocorticoid receptor DNA-binding domain: sequential assignments and identification of secondary structure elements. Nature 352: 497-505.
33. BOURGUET, W., P. GERMAIN & H. GRONEMEYER. 2000. Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications. Trends Pharmacol. Sci. 21: 381-388.
34. BLEDSOE, R.K., V.G. MONTANA, T.B. STANLEY, et al. 2002. Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 110: 93-105.
35. OWENS-GRILLO, J.K., K. HOFFMANN, K.A. HUTCHISON, et al. 1995. The cyclosporin A-binding immunophilin CyP-40 and the FK506-binding immunophilin hsp56 bind to a common site on hsp90 and exist in independent cytosolic heterocomplexes with the untransformed glucocorticoid receptor. J. Biol. Chem. 270: 20479-20484.
36. HUTCHISON, K.A., L.F. STANCATO, J.K. OWENS-GRILLO, et al. 1995. The 23-kDa acidic protein in reticulocyte lysate is the weakly bound component of the hsp foldosome that is required for assembly of the glucocorticoid receptor into a functional heterocomplex with hsp90. J. Biol. Chem. 270: 18841-18847.
37. DENIS, M., J.A. GUSTAFSSON & A.C. WIKSTROM. 1988. Interaction of the Mr = 90,000 heat shock protein with the steroid-binding domain of the glucocorticoid receptor. J. Biol. Chem. 263: 18520-18523.
38. CZAR, M.J., R.H. LYONS, M.J. WELSH, et al. 1995. Evidence that the FK506-binding immunophilin heat shock protein 56 is required for trafficking of the glucocorticoid receptor from the cytoplasm to the nucleus. Mol. Endocrinol. 9: 1549-1560.
39. SAVORY, J.G., B. HSU, I.R. LAQUIAN, et al. 1999. Discrimination between NL1- and NL2-mediated nuclear localization of the glucocorticoid receptor. Mol. Cell. Biol. 19: 1025-1037.
40. MCKENNA, N.J., R.B. LANZ & B.W. O'MALLEY. 1999. Nuclear receptor coregulators: cellular and molecular biology. Endocr. Rev. 20: 321-344.
41. WANG, L.H., S.Y. TSAI, R.G. COOK, et al. 1989. COUP transcription factor is a member of the steroid receptor superfamily. Nature 340: 163-166.
42. MALIK, S. & S. KARATHANASIS. 1995. Transcriptional activation by the orphan nuclear receptor ARP-1. Nucleic Acids Res. 23: 1536-1543.
43. BUTLER, A.J. & M.G. PARKER. 1995. COUP-TF II homodimers are formed in preference to heterodimers with RXR alpha or TR beta in intact cells. Nucleic Acids Res. 23: 4143-1150.
44. SHIBATA, H., Z. NAWAZ, S.Y. TSAI, et al. 1997. Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT). Mol. Endocrinol. 11: 714-724.
45. STROUP, D. & J.Y. CHIANG. 2000. HNF4 and COUP-TFII interact to modulate transcription of the cholesterol 7alpha-hydroxylase gene (CYP7A1). J. Lipid Res. 41: 1-11.
46. STROUP, D., M. CRESTANI & J.Y. CHIANG. 1997. Orphan receptors chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) and retinoid X receptor (RXR) activate and bind the rat cholesterol 7alpha-hydroxylase gene (CYP7A). J. Biol. Chem. 272: 9833-9839.
47. STAFFORD, J.M., M. WALTNER-LAW & D.K. GRANNER. 2001. Role of accessory factors and steroid receptor coactivator 1 in the regulation of phosphoenolpyruvate carboxykinase gene transcription by glucocorticoids. J. Biol. Chem. 276: 3811-3819.
48. DAVIS, R.A., J.H. MIYAKE, T.Y. HUI & N.J. SPANN. 2002. Regulation of cholesterol-7alpha-hydroxylase: BAREly missing a SHP. J. Lipid Res. 43: 533-543.
49. MILLER, W.L. & G.P. CHROUSOS. 2001. The adrenal cortex. In Endocrinology & Metabolism. P. Felig & L.A. Frohman, Eds.: 387-524. McGraw-Hill. New York.
50. STALMANS, W. & M. LALOUX. 1979. Glucocorticoids and hepatic glycogen metabolism. Monogr. Endocrinol. 12: 517-533.
51. OLEFSKY, J.M. 1975. Effect of dexamethasone on insulin binding, glucose transport, and glucose oxidation of isolated rat adipocytes. J. Clin. Invest. 56: 1499-1508.
52. SAKODA, H., T. OGIHARA, M. ANAI, et al. 2000. Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes 49: 1700-1708.
53. WEINSTEIN, S.P., T. PAQUIN, A. PRITSKER & R.S. HABER. 1995. Glucocorticoid-induced insulin resistance: dexamethasone inhibits the activation of glucose transport in rat skeletal muscle by both insulin- and non-insulin-related stimuli. Diabetes 44: 441-445.
54. OGAWA, A., J.H. JOHNSON, M. OHNEDA, et al. 1992. Roles of insulin resistance and beta-cell dysfunction in dexamethasone-induced diabetes. J. Clin. Invest. 90: 497-504.
55. PHILIPPE, J. & M. MISSOTTEN. 1990. Dexamethasone inhibits insulin biosynthesis by destabilizing insulin messenger ribonucleic acid in hamster insulinoma cells. Endocrinology 127: 1640-1645.
56. GRILL, V., M. ALVARSSON & S. EFENDIC. 1992. Dexamethasone treatment fails to increase arginine-induced insulin release in healthy subjects with low insulin response. Diabetologia 35: 367-371.
57. COUFALIK, A.H. & C. MONDER. 1981. Stimulation of gluconeogenesis by cortisol in fetal rat liver in organ culture. Endocrinology 108: 1132-1137.
58. VAN DE WERVE, G., A. LANGE, C. NEWGARD, et al. 2000. New lessons in the regulation of glucose metabolism taught by the glucose 6-phosphatase system. Eur. J. Biochem. 267: 1533-1549.
59. WANG, J.C., P.E. STROMSTEDT, T. SUGIYAMA & D.K. GRANNER. 1999. The phosphoenolpyruvate carboxykinase gene glucocorticoid response unit: identification of the functional domains of accessory factors HNF3 beta (hepatic nuclear factor-3 beta) and HNF4 and the necessity of proper alignment of their cognate binding sites. Mol. Endocrinol. 13: 604-618.
60. STAFFORD, J.M., J.C. WILKINSON, J.M. BEECHEM & D.K. GRANNER. 2001. Accessory factors facilitate the binding of glucocorticoid receptor to the phosphoenolpyruvate carboxykinase gene promoter. J. Biol. Chem. 276: 39885-39891.
61. HALL, R.K., F.M. SLADEK & D.K. GRANNER. 1995. The orphan receptors COUP-TF and HNF-4 serve as accessory factors required for induction of phosphoenolpyruvate carboxykinase gene transcription by glucocorticoids. Proc. Natl. Acad. Sci. USA 92: 412-416.
62. YOON, J.C., P. PUIGSERVER, G. CHEN, et al. 2001. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413: 131-138.
63. RHEE, J., Y. INOUE, J.C. YOON, et al. 2003. Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis. Proc. Natl. Acad. Sci. USA 100: 4012-4017.
64. ETTINGER, W.H., JR. & W.R. HAZZARD. 1988. Prednisone increases very low density lipoprotein and high density lipoprotein in healthy men. Metabolism 37: 1055-1058.
65. AVIGAN, J. 1977. Studies on the effects of hormones on cholesterol synthesis in mammalian cells in culture. Expo. Annu. Biochim. Med. 33: 1-11
66. AL RAYYES, O., A. WALLMARK & C.H. FLOREN. 1997. Additive inhibitory effect of hydrocortisone and cyclosporine on low-density lipoprotein receptor activity in cultured HepG2 cells. Hepatology 26: 967-971.
67. VARMA, V.K., T.K. SMITH, M. SORCI-THOMAS & W.H. ETTINGER, JR. 1992. Dexamethasone increases apolipoprotein A-I concentrations in medium and apolipoprotein A-I mRNA abundance from Hep G2 cells. Metabolism 41: 1075-1080.
68. PARKER, C.R., JR., P.C. MACDONALD, B.R. CARR & J.C. MORRISON. 1987. The effects of dexamethasone and anencephaly on newborn serum levels of apolipoprotein A-1. J. Clin. Endocrinol. Metab. 65: 1098-1101.
69. LADIAS, J.A. & S.K. KARATHANASIS. 1991. Regulation of the apolipoprotein AI gene by ARP-1, a novel member of the steroid receptor superfamily. Science 251: 561-565.
70. BEEKMAN, J.M., J. WIJNHOLDS, I.J. SCHIPPERS, et al. 1991. Regulatory elements and DNA-binding proteins mediating transcription from the chicken very-low-density apolipoprotein II gene. Nucleic Acids Res. 19: 5371-5377.
71. LADIAS, J.A., M. HADZOPOULOU-CLADARAS, D. KARDASSIS, et al. 1992. Transcriptional regulation of human apolipoprotein genes ApoB, ApoCIII, and ApoAII by members of the steroid hormone receptor superfamily HNF-4, ARP-1, EAR-2, and EAR-3. J. Biol. Chem. 267: 15849-15860.
72. PRINCEN, H.M., P. MEIJER & B. HOFSTEE. 1989. Dexamethasone regulates bile acid synthesis in monolayer cultures of rat hepatocytes by induction of cholesterol 7 alpha-hydroxylase. Biochem. J. 262: 341-348.
73. ELLIS, E., B. GOODWIN, A. ABRAHAMSSON, et al. 1998. Bile acid synthesis in primary cultures of rat and human hepatocytes. Hepatology 27: 615-620.
74. QUATTROCHI, L.C. & P.S. GUZELIAN. 2001. Cyp3A regulation: from pharmacology to nuclear receptors. Drug Metab. Dispos. 29: 615-622.
75. HUNT, C.M., P.B. WATKINS, P. SAENGER, et al. 1992. Heterogeneity of CYP3A isoforms metabolizing erythromycin and cortisol. Clin. Pharmacol. Ther. 51: 18-23
76. HUSS, J.M. & C.B. KASPER. 1998. Nuclear receptor involvement in the regulation of rat cytochrome P450 3A23 expression. J. Biol. Chem. 273: 16155-16162.
77. HUSS, J.M., S.I. WANG, A. ASTROM, et al. 1996. Dexamethasone responsiveness of a major glucocorticoid-inducible CYP3A gene is mediated by elements unrelated to a glucocorticoid receptor binding motif. Proc. Natl. Acad. Sci. USA 93: 4666-4670.
78. QUATTROCHI, L.C., C.B. YOCKEY, J.L. BARWICK & P.S. GUZELIAN. 1998. Characterization of DNA-binding proteins required for glucocorticoid induction of CYP3A23. Arch. Biochem. Biophys. 349: 251-260.
79. KLIEWER, S.A., J.T. MOORE, L. WADE, et al. 1998. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 92: 73-82.
80. LECLUYSE, E.L. 2001. Pregnane X receptor: molecular basis for species differences in CYP3A induction by xenobiotics. Chem. Biol. Interact. 134: 283-289.
81. OGINO, M., K. NAGATA, M. MIYATA & Y. YAMAZOE. 1999. Hepatocyte nuclear factor 4-mediated activation of rat CYP3A1 gene and its modes of modulation by apolipoprotein AI regulatory protein I and v-ErbA-related protein 3. Arch. Biochem. Biophys. 362: 32-37.
82. HUSS, J.M., S.I. WANG & C.B. KASPER. 1999. Differential glucocorticoid responses of CYP3A23 and CYP3A2 are mediated by selective binding of orphan nuclear receptors. Arch. Biochem. Biophys. 372: 321-332.
83. HUSS, J.M. & C.B. KASPER. 2000. Two-stage glucocorticoid induction of CYP3A23 through both the glucocorticoid and pregnane X receptors. Mol. Pharmacol. 58: 48-57.